Skip to main content
. 2018 Jan 29;45(1):180–189. doi: 10.1093/schbul/sbx190

Table 2.

MRS Metabolite Levels and Quality Measuresa,b

Measure Control (n = 21) Schizophrenia (n = 21) Statistic P value
Glutamate 6.93 (0.50) 6.57 (0.50) F(1,37) = 4.70 .04
 CRLB 2.0% 2.1%
Glutamine 1.91 (0.23) 1.82 (0.32) F(1,37) = 1.15 .29
 CRLB 5.8% 6.7%
Glutamine/Glutamate 0.28 (0.04) 0.28 (0.04) F(1,37) = 0.01 .92
GABA 0.93 (0.18) 0.91 (0.18) F(1,37) = 0.03 .87
 CRLB 11.0% 11.9%
Total NAA (NAA + NAAG) 7.27 (0.60) 6.84 (0.53) F(1,37) = 5.06 .03
 CRLB 1.4% 1.6%
NAA 6.82 (0.53) 6.46 (0.50) F(1,37) = 3.56 .07
 CRLB 1.7% 2.0%
NAAG 0.46 (0.10) 0.45 (0.08) F(1,31) = 1.21 .28
 CRLB 16.4% 17.0%
Total Creatine (Cr + PCr) 5.74 (0.38) 5.73 (0.42) F(1,37) = 0.45 .51
 CRLB 1.7% 1.9%
Creatine (Cr) 2.39 (0.22) 2.33 (0.34) F(1,36) = 0.64 .43
 CRLB 8.6% 9.3%
Phosphocreatine (PCr) 3.36 (0.35) 3.44 (0.43) F(1,37) = 0.07 .79
 CRLB 6.9% 7.2%
Total Choline (Cho + PCh) 1.30 (0.17) 1.34 (0.16) F(1,37) = 0.07 .79
 CRLB 3.3% 3.4%
Glutathione 0.75 (0.10) 0.70 (0.11) F(1,37) = 1.48 .23
 CRLB 8.9% 10.4%
myo-Inositol 5.03 (0.50) 4.88 (0.47) F(1,37) = 1.92 .17
 CRLB 2.3% 2.5%
Taurine 1.48 (0.12) 1.59 (0.27) F(1,37) = 1.42 .24
 CRLB 7.4% 7.4%
Aspartate 1.49 (0.21) 1.45 (0.23) F(1,34) = 1.18 .29
 CRLB 13.6% 14.7%
SNR 35.0 (3.6) 31.7 (7.0) t(40) = 1.89 .07
FWHM, ppm 0.03 (0.003) 0.03 (0.005) t(40) = 1.73 .09
GM, % 71.4 (7.8) 73.6 (8.6) t(40) = 0.88 .39
WM, % 25.4 (7.7) 23.7 (8.7) t(40) = 0.67 .51
CSF, % 2.5 (1.6) 2.1 (1.7) t(40) = 0.69 .49
GM/(GM+WM), % 73.7 (8.0) 75.6 (9.0) t(40) = 0.72 .47

Note: Cho, choline; Cr, creatine; CRLB, Cramer-Rao lower bounds; CSF, cerebrospinal fluid; FWHM, full-width at half maximum; GABA, gamma-aminobutyric acid; GPC, glycerophosphocholine; GM, gray matter; NAA, N-acetylaspartate; NAAG, N-acetylaspartylglutamate; PCh, phosphocholine; PCr, phosphocreatine; ppm, parts-per-million; SNR, signal-to-noise ratio; WM, white matter.

aMean (SD).

bAll metabolite levels are in institutional units.